Country: United States
Language: English
Source: NLM (National Library of Medicine)
METHYLPREDNISOLONE (UNII: X4W7ZR7023) (METHYLPREDNISOLONE - UNII:X4W7ZR7023)
Preferred Pharmaceuticals, Inc.
METHYLPREDNISOLONE
METHYLPREDNISOLONE 4 mg
ORAL
PRESCRIPTION DRUG
MethylPREDNISolone Tablets are indicated in the following conditions: Systemic fungal infections and known hypersensitivity to components.
MethylPREDNISolone Tablets are available in the following strengths and package sizes: 4 mg (white, oval, quadrisect tablets debossed “42/16/V” on one side and debossed “4” on the reverse side)
Abbreviated New Drug Application
METHYLPREDNISOLONE- METHYLPREDNISOLONE TABLET PREFERRED PHARMACEUTICALS, INC. ---------- METHYLPREDNISOLONE TABLETS, USP 4 MG RX ONLY DESCRIPTION Methylprednisolone is a glucocorticoid. Glucocorticoids are adrenocortical steroids, both naturally occurring and synthetic, which are readily absorbed from the gastrointestinal tract. Methylprednisolone occurs as a white to practically white, odorless, crystalline powder. It is sparingly soluble in alcohol, in dioxane, and in methanol, slightly soluble in acetone, and in chloroform, and very slightly soluble in ether. It is practically insoluble in water. The chemical name for methylprednisolone is pregna-1,4-diene-3,20-dione, 11,17,21-trihydroxy-6- methyl-, (6α,11β)-, and the molecular weight is 374.48. The structural formula is represented below: Each MethylPREDNISolone Tablet for oral administration contains 4 mg methylprednisolone. CLINICAL PHARMACOLOGY Naturally occurring glucocorticoids (hydrocortisone and cortisone), which also have salt-retaining properties, are used as replacement therapy in adrenocortical deficiency states. Their synthetic analogs are primarily used for their potent anti-inflammatory effects in disorders of many organ systems. Glucocorticoids cause profound and varied metabolic effects. In addition, they modify the body's immune responses to diverse stimuli. INDICATIONS AND USAGE MethylPREDNISolone Tablets are indicated in the following conditions: 1. 2. 3. 4. 5. 6. ENDOCRINE DISORDERS Primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the first choice; synthetic analogs may be used in conjunction with mineralocorticoids where applicable; in infancy mineralocorticoid supplementation is of particular importance). Congenital adrenal hyperplasia Hypercalcemia associated with cancer Nonsuppurative thyroiditis RHEUMATIC DISORDERS As adjunctive therapy for short-term administration (to tide the patient over an acute episode or exacerbation) in: Rheumatoid arthritis, including juvenile rheumatoid arthritis (selected Read the complete document